The C-terminal module IV of connective tissue growth factor is a novel immune modulator of the Th17 response

The C-terminal module IV of connective tissue growth factor is a novel immune modulator of the Th17 response
复制标题

结缔组织生长因子的C端模块IV是Th17反应的新型免疫调节剂

DOI:
--
复制
发表时间:
2013
影响因子:
5
通讯作者:
M. Ruíz
M. Ruíz
中科院分区:
医学2区
文献类型:
--
作者:
R. Rodrigues;Raúl R. Rodrigues;S. Rayego‐Mateos;B. Suarez;Carolina Lavoz;L. Aroeira;E. Sanchez;M. Orejudo;M. Alique;C. López;A. Ortiz;J. Egido;M. Ruíz

文献摘要

参考文献

被引文献

相似文献

结缔组织生长因子(CTGF/CCN 2)是一种易被蛋白水解降解的基质细胞蛋白。CCN 2水平已被认为是几种慢性疾病的潜在风险生物标志物。在体液中,可以发现CCN 2全长及其降解片段;然而,它们的体内作用远未阐明。CCN 2被描述为促纤维化介质,但这一概念正在转变为促炎细胞因子。在体外,CCN 2全长及其C-末端模块IV(CCN 2(IV))发挥促炎特性。新出现的证据表明,Th 17细胞及其效应细胞因子IL-17 A参与慢性炎症性疾病。我们的目的是探索CCN 2(IV)是否可以调节Th 17应答。在体外,用CCN 2(IV)刺激人幼稚CD 4 + T淋巴细胞导致分化为Th 17表型。在C57 BL/6小鼠中研究了CCN 2(IV)的体内作用。腹腔注射重组CCN 2(IV)不改变血清IL-17 A水平,但引起肾脏中Th 17应答的激活,其特征在于Th 17(IL 17 A +/CD 4+)细胞的间质浸润和促炎介质的上调。在CCN 2(IV)注射小鼠中,发现Th 17相关因子(IL-17 A、IL-6、STAT 3和RORγt)的肾脏水平升高,而Th 1/Th 2细胞因子或Treg相关因子(TGF-β和Foxp-3)未发生变化。用抗IL-17 A中和抗体治疗减少了CCN 2(IV)诱导的肾脏炎症。我们的研究结果揭示了CCN 2的C-末端模块诱导人Th 17细胞的Th 17分化并引起肾脏Th 17炎症反应。此外,这些数据证明IL-17 A靶向是治疗慢性炎性疾病(包括肾脏病理)的有前景的工具。
Connective tissue growth factor (CTGF/CCN2) is a matricellular protein susceptible to proteolytic degradation. CCN2 levels have been suggested as a potential risk biomarker in several chronic diseases. In body fluids, CCN2 full-length and its degradation fragments can be found; however, their in vivo effects are far from being elucidated. CCN2 was described as a profibrotic mediator, but this concept is changing to a proinflammatory cytokine. In vitro, CCN2 full-length and its C-terminal module IV (CCN2(IV)) exert proinflammatory properties. Emerging evidence suggest that Th17 cells, and its effector cytokine IL-17A, participate in chronic inflammatory diseases. Our aim was to explore whether CCN2(IV) could regulate the Th17 response. In vitro, stimulation of human naive CD4+ T lymphocytes with CCN2(IV) resulted in differentiation to Th17 phenotype. The in vivo effects of CCN2(IV) were studied in C57BL/6 mice. Intraperitoneal administration of recombinant CCN2(IV) did not change serum IL-17A levels, but caused an activation of the Th17 response in the kidney, characterized by interstitial infiltration of Th17 (IL17A+/CD4+) cells and upregulation of proinflammatory mediators. In CCN2(IV)-injected mice, elevated renal levels of Th17-related factors (IL-17A, IL-6, STAT3 and RORγt) were found, whereas Th1/Th2 cytokines or Treg-related factors (TGF-β and Foxp-3) were not modified. Treatment with an anti-IL-17A neutralizing antibody diminished CCN2(IV)-induced renal inflammation. Our findings unveil that the C-terminal module of CCN2 induces the Th17 differentiation of human Th17 cells and causes a renal Th17 inflammatory response. Furthermore, these data bear out that IL-17A targeting is a promising tool for chronic inflammatory diseases, including renal pathologies.
DOI: 10.1038/ki.2008.394
发表时间: 2008-11
影响因子: 19.6
作者:
Dong, Xiangyang;Bachman, Lori A.;Miller, Melinda N.;Nath, Karl A.;Griffin, Matthew D.
通讯作者: Griffin, Matthew D.
DOI: 10.1053/j.ajkd.2010.11.022
发表时间: 2011-06
期刊: American journal of kidney diseases : the official journal of the National Kidney Foundation
影响因子: --
作者:
O'Seaghdha CM;Hwang SJ;Bhavsar NA;Köttgen A;Coresh J;Astor BC;Fox CS
通讯作者: Fox CS
DOI: 10.2217/imt.10.33
发表时间: 2010-07
期刊: Immunotherapy
影响因子: 2.8
作者:
Booth AJ;Bishop DK
通讯作者: Bishop DK
DOI: 10.1172/jci38702
发表时间: 2010-01-01
影响因子: 15.9
作者:
Li, Li;Huang, Liping;Okusa, Mark D.
通讯作者: Okusa, Mark D.